Tests a home care program for people with COPD after a flare-up
Tests a remote rehabilitation and monitoring program for adults with COPD after hospital discharge.
Plain-language title generated from the registry record
Registry title: CHARM-COPD Program of Care
Key facts
- Where
- Toronto, CanadaSee the site
Where in Canada
- University Health NetworkToronto, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Health Network, Toronto
- Trial code
- NCT06253013
- Record updated
- 22 June 2026
- Original description
The investigators' goal for this project is to evaluate the feasibility, acceptability, and actual usage of a program of care for patients with COPD recently discharged after an acute exacerbation. The program of care includes virtual pulmonary rehabilitation, integrated care, and remote clinical monitoring.Read full original descriptionShow less
A Program of Care in Chronic Obstructive Pulmonary Disease Involving Virtual Pulmonary Rehabilitation, Integrated Care and Remote Clinical Monitoring After Discharge From a Recent Exacerbation: Mixed-Methods Study on Feasibility
The investigators' goal for this project is to evaluate the feasibility, acceptability, and actual usage of a program of care for patients with COPD recently discharged after an acute exacerbation. The program of care includes virtual pulmonary rehabilitation, integrated care, and remote clinical monitoring.
Inclusion: Referred to either Virtual Pulmonary Rehabilitation or Remote Clinical Monitoring at Toronto Grace Health Centre after discharge from UHN hospital with an AECOPD as defined by the clinical team.
Exclusion: Pulmonary condition other than COPD as the main respiratory disease such as bronchiectasis or asthma; Significant cognitive impairment and absence/inability of a family caregiver to consent and to follow study processes; Projected life expectancy ≤ 2 months , as determined by the clinical team.